Condensed Consolidated Statement Of Stockholders' Equity Deficit (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 20,000	$ 12,793	$ 5,180,816	$ (6,060,923)	$ (680,180)	$ (1,527,494)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	5,000,000	12,793,357
Net income (loss)				(436,026)	(42,019)	(478,045)
Ending balance, value at Mar. 31, 2021	$ 20,000	$ 12,793	5,180,816	(6,496,949)	(722,199)	(2,005,539)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	5,000,000	12,793,357
Beginning balance, value at Dec. 31, 2020	$ 20,000	$ 12,793	5,180,816	(6,060,923)	(680,180)	(1,527,494)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	5,000,000	12,793,357
Net income (loss)						(2,394,762)
Ending balance, value at Jun. 30, 2021	$ 20,000	$ 22,793	5,038,167	(8,375,611)	(627,605)	(3,922,256)
Shares, Outstanding, Ending Balance at Jun. 30, 2021	5,000,000	22,793,357
Beginning balance, value at Mar. 31, 2021	$ 20,000	$ 12,793	5,180,816	(6,496,949)	(722,199)	(2,005,539)
Shares, Outstanding, Beginning Balance at Mar. 31, 2021	5,000,000	12,793,357
Net income (loss)				(1,878,662)	(38,055)	(1,916,717)
Shares issued to acquire additional interest in subsidiary		$ 10,000	(142,649)		132,649
Shares issued to acquire additional interest in subsidiary, shares		10,000,000
Ending balance, value at Jun. 30, 2021	$ 20,000	$ 22,793	5,038,167	(8,375,611)	(627,605)	(3,922,256)
Shares, Outstanding, Ending Balance at Jun. 30, 2021	5,000,000	22,793,357
Beginning balance, value at Dec. 31, 2021	$ 20,000	$ 25,178	10,784,308	(16,092,531)	(659,890)	(5,922,935)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	5,000,000	25,177,973
Shares issued as financing costs		$ 11	22,389			22,400
Shares issued as financing costs, shares		10,769
Net income (loss)				(2,937,633)	(599)	(2,938,232)
Ending balance, value at Mar. 31, 2022	$ 20,000	$ 25,189	10,806,697	(19,030,164)	(660,489)	(8,838,767)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	5,000,000	25,188,742
Beginning balance, value at Dec. 31, 2021	$ 20,000	$ 25,178	10,784,308	(16,092,531)	(659,890)	(5,922,935)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	5,000,000	25,177,973
Net income (loss)						(6,440,580)
Ending balance, value at Jun. 30, 2022	$ 20,000	$ 27,802	12,233,626	(22,516,357)	(676,644)	(10,911,573)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	5,000,000	27,802,050
Beginning balance, value at Mar. 31, 2022	$ 20,000	$ 25,189	10,806,697	(19,030,164)	(660,489)	(8,838,767)
Shares, Outstanding, Beginning Balance at Mar. 31, 2022	5,000,000	25,188,742
Net income (loss)				(3,486,193)	(16,155)	(3,502,348)
Cashless warrants exercise		$ 356	(356)
Cashless warrants exercise, shares		356,364
Shares issued under consulting agreement		$ 1,869	658,131			660,000
Shares issued under consulitng agreement		1,869,463
Shares issued under Equity Purchase Agreement		$ 388	35,641			36,029
Shares issued under Equity Purchase Agreement, shares		387,481
Beneficial conversion feature under convertible notes with warrants			724,500			724,500
Repricing of warrants			9,013			9,013
Ending balance, value at Jun. 30, 2022	$ 20,000	$ 27,802	$ 12,233,626	$ (22,516,357)	$ (676,644)	$ (10,911,573)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	5,000,000	27,802,050